Evidence map›Paper›PMID 28827734›Full record

ArticleScientific reports2017

Integrative epigenomics, transcriptomics and proteomics of patient chondrocytes reveal genes and pathways involved in osteoarthritis.

Julia Steinberg, Graham R S Ritchie, Theodoros I Roumeliotis, Raveen L Jayasuriya, Matthew J Clark, Roger A Brooks, Abbie L A Binch, Karan M Shah, Rachael Coyle, Mercedes Pardo and 8 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 71 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
71citing papers in PubMed, 2 pooled it
12.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

71 citing papers in PubMed, 2 syntheses or guidelines pooled it, 119 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Review
  5. Article
  6. Review
  7. RMD open · 2025
    Article
  8. Review
  9. Review
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article

11 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 6 institutions in 3 countries.

Julia SteinbergWellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, CB10 1SA, UK.
Graham R S RitchieWellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, CB10 1SA, UK.
Theodoros I RoumeliotisWellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, CB10 1SA, UK.
Raveen L JayasuriyaDepartment of Oncology and Metabolism, University of Sheffield, Beech Hill Road, Sheffield, S10 2RX, UK.
Matthew J ClarkDepartment of Oncology and Metabolism, University of Sheffield, Beech Hill Road, Sheffield, S10 2RX, UK.
Roger A BrooksDivision of Trauma & Orthopaedic Surgery, University of Cambridge, Box 180, Addenbrooke's Hospital, Hills Road, Cambridge, CB2 0QQ, UK.
Abbie L A BinchBiomolecular Sciences Research Centre, Sheffield Hallam University, Sheffield, S1 1WB, UK.
Karan M ShahDepartment of Oncology and Metabolism, University of Sheffield, Beech Hill Road, Sheffield, S10 2RX, UK.
Rachael CoyleWellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, CB10 1SA, UK.
Mercedes PardoWellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, CB10 1SA, UK.ORCID 0000-0002-3477-9695
Christine L Le MaitreBiomolecular Sciences Research Centre, Sheffield Hallam University, Sheffield, S1 1WB, UK.
Yolande F M RamosDepartment of Medical Statistics and Bioinformatics, Section Molecular Epidemiology, Leiden University Medical Center, Leiden, 2300RC, The Netherlands.ORCID 0000-0003-1459-413X
Rob G H H NelissenDepartment of Orthopedics, Leiden University Medical Center, Leiden, 2300RC, The Netherlands.
Ingrid MeulenbeltDepartment of Medical Statistics and Bioinformatics, Section Molecular Epidemiology, Leiden University Medical Center, Leiden, 2300RC, The Netherlands.
Andrew W McCaskieDivision of Trauma & Orthopaedic Surgery, University of Cambridge, Box 180, Addenbrooke's Hospital, Hills Road, Cambridge, CB2 0QQ, UK.
Jyoti S ChoudharyWellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, CB10 1SA, UK.
J Mark WilkinsonDepartment of Oncology and Metabolism, University of Sheffield, Beech Hill Road, Sheffield, S10 2RX, UK. j.m.wilkinson@sheffield.ac.uk.ORCID 0000-0001-5577-3674
Eleftheria ZegginiWellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, CB10 1SA, UK. Eleftheria@sanger.ac.uk.ORCID 0000-0003-4238-659X
Wellcome Sanger Institute · GBUniversity of Sheffield · GBLeiden University Medical Center · NLSheffield Hallam University · GBUniversity of Cambridge · GBEuropean Bioinformatics Institute · GB

Funding

Medical Research Council MC_PC_12009Medical Research Council MR/P020941/1Wellcome Trust WT098051
6 · The paper itself

Abstract

Osteoarthritis (OA) is a common disease characterized by cartilage degeneration and joint remodeling. The underlying molecular changes underpinning disease progression are incompletely understood. We investigated genes and pathways that mark OA progression in isolated primary chondrocytes taken from paired intact versus degraded articular cartilage samples across 38 patients undergoing joint replacement surgery (discovery cohort: 12 knee OA, replication cohorts: 17 knee OA, 9 hip OA patients). We combined genome-wide DNA methylation, RNA sequencing, and quantitative proteomics data. We identified 49 genes differentially regulated between intact and degraded cartilage in at least two -omics levels, 16 of which have not previously been implicated in OA progression. Integrated pathway analysis implicated the involvement of extracellular matrix degradation, collagen catabolism and angiogenesis in disease progression. Using independent replication datasets, we showed that the direction of change is consistent for over 90% of differentially expressed genes and differentially methylated CpG probes. AQP1, COL1A1 and CLEC3B were significantly differentially regulated across all three -omics levels, confirming their differential expression in human disease. Through integration of genome-wide methylation, gene and protein expression data in human primary chondrocytes, we identified consistent molecular players in OA progression that replicated across independent datasets and that have translational potential.

Indexed as

DNA MethylationAquaporin 1Arthroplasty, Replacement, HipArthroplasty, Replacement, KneeCase-Control StudiesChondrocytesChromatography, LiquidCollagen Type ICollagen Type I, alpha 1 ChainDisease ProgressionEpigenesis, GeneticEpigenomicsGene Expression ProfilingGene Regulatory NetworksHumansLectins, C-TypeAQP1 protein, humanAquaporin 1Collagen Type ICollagen Type I, alpha 1 ChainLectins, C-Typetetranectin

Identifiers

PMID28827734
PMCPMC5566454
OpenAlexW2750246616

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.